≡

Multiplex Assay Kit for Dihydrodiol Dehydrogenase 2 (DDH2) ,etc. by FLIA (Flow Luminescence Immunoassay)

AKR1C2; DD; BABP; DD2; HAKRD; MCDR2; Aldo-Keto Reductase Family 1,Member C2; Bile Acid Binding Protein; 3-Alpha Hydroxysteroid Dehydrogenase Type III

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Dihydrodiol Dehydrogenase 2 (DDH2) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Dihydrodiol Dehydrogenase 2 (DDH2) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Dihydrodiol Dehydrogenase 2 (DDH2) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Dihydrodiol Dehydrogenase 2 (DDH2) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 81-104 90
EDTA plasma(n=5) 89-99 95
heparin plasma(n=5) 83-102 89
sodium citrate plasma(n=5) 88-96 93

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Dihydrodiol Dehydrogenase 2 (DDH2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Dihydrodiol Dehydrogenase 2 (DDH2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Dihydrodiol Dehydrogenase 2 (DDH2) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 81-101% 84-98% 94-103% 80-90%
EDTA plasma(n=5) 88-102% 97-104% 88-99% 82-89%
heparin plasma(n=5) 86-98% 94-101% 91-101% 98-105%
sodium citrate plasma(n=5) 80-101% 90-98% 81-96% 99-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:DDH2) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Lung Cancer Proteomics-based identification of secreted protein dihydrodiol dehydrogenase 2 as a potential biomarker for predicting cisplatin efficacy in advanced NSCLC patients ScienceDirect: S0169500212001274
Clinical and Experimental Optometry Aldo-keto reductase and sorbitol dehydrogenase enzymes in Egyptian diabetic patients with and without proliferative diabetic retinopathy. Pubmed: 23452182
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPQ200Hu01 Recombinant Dihydrodiol Dehydrogenase 2 (DDH2) Positive Control; Immunogen; SDS-PAGE; WB.
PAQ200Hu01 Polyclonal Antibody to Dihydrodiol Dehydrogenase 2 (DDH2) WB; IHC; ICC; IP.
MAQ200Hu21 Monoclonal Antibody to Dihydrodiol Dehydrogenase 2 (DDH2) WB; IHC; ICC; IP.
SEQ200Hu ELISA Kit for Dihydrodiol Dehydrogenase 2 (DDH2) Enzyme-linked immunosorbent assay for Antigen Detection.
LMQ200Hu Multiplex Assay Kit for Dihydrodiol Dehydrogenase 2 (DDH2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.